XML 21 R7.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Additional paid-in capital
Additional paid-in capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated other comprehensive income (loss)
Retained earnings (accumulated deficit)
Retained earnings (accumulated deficit)
Cumulative Effect, Period of Adoption, Adjustment
Common stock
Common stock
Balance (in shares) at Jul. 31, 2022               84,084,209
Balance, beginning at Jul. 31, 2022 $ 1,451,657 $ (28,309) $ 1,755,476 $ (68,003) $ (19,845) $ (283,982) $ 39,694 $ 8
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) $ (111,855)         (111,855)    
Issuance of common stock upon exercise of stock options (in shares) 6,582             6,582
Issuance of common stock upon exercise of stock options $ 228   228          
Issuance of common stock upon RSU release (in shares)               1,391,162
Stock-based compensation 143,566   143,566          
Repurchase and retirement of common stock 2,642       2,642      
Foreign currency translation adjustment 4,324       4,324      
Unrealized gain (loss) on available-for-sale securities, net of tax (980)       (980)      
Repurchase and retirement of common stock (in shares)               (4,041,284)
Repurchase and retirement of common stock (261,807)         (261,807)    
Balance (in shares) at Jul. 31, 2023               81,440,669
Balance, ending at Jul. 31, 2023 1,199,466   1,831,267   (13,859) (617,950)   $ 8
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) $ (6,103)         (6,103)    
Issuance of common stock upon exercise of stock options (in shares) 15,517             15,517
Issuance of common stock upon exercise of stock options $ 1,054   1,054          
Issuance of common stock upon RSU release (in shares)               1,569,451
Stock-based compensation 146,700   146,700          
Repurchase and retirement of common stock (1,640)       (1,640)      
Foreign currency translation adjustment 3,948       3,948      
Unrealized gain (loss) on available-for-sale securities, net of tax (693)       (693)      
Balance (in shares) at Jul. 31, 2024               83,025,637
Balance, ending at Jul. 31, 2024 1,342,732   1,979,021   (12,244) (624,053)   $ 8
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) $ 69,804         69,804    
Issuance of common stock upon exercise of stock options (in shares) 56,880             56,880
Issuance of common stock upon exercise of stock options $ 3,902   3,902          
Issuance of common stock upon RSU release (in shares)               1,473,839
Stock-based compensation 161,678   161,678          
Purchase of capped calls (58,788)   (58,788)          
Retirement of convertible senior notes (79,366)   (79,366)          
Deferred tax asset related to debt issuance of convertible senior notes 13,952   13,952          
Settlement of convertible senior notes (in shares)               671,202
Settlement of convertible senior notes (6)   (6)          
Settlement of capped calls               697,140
Repurchase and retirement of common stock 3,668       3,668      
Foreign currency translation adjustment (500)       (500)      
Unrealized gain (loss) on available-for-sale securities, net of tax 154       154      
Balance (in shares) at Jul. 31, 2025               84,530,418
Balance, ending at Jul. 31, 2025 $ 1,457,230   $ 2,020,393   $ (8,922) $ (554,249)   $ 8